GGrantIndex
← Leaderboards

Pamela J McLean

Massachusetts General Hospital

$8,514,689
Attributed
$9,741,098
Total exposure
7
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.1M · FY200925
$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$24,279,253 · 8

By mechanism

U54$17,430,344 · 3
R01$6,029,407 · 3
R21$433,600 · 1
P30$385,902 · 1

Top collaborators

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsAlpha SynucleinNeuronsProteinsParkinson DiseaseIn VivoPathway InteractionsBrainToxic EffectGeneticPathogenesisAutopsyNerve DegenerationPreventTissuesProteomicsMutationPathologicLewy Body DementiaAlzheimer&AposLewy BodiesDisease ProgressionNeuropathologyLewy Body Disease

Grant awards (31)

Research Education Component$192,951
P30 · FY2025 · AG · contact PI
Research Education Component$192,951
P30 · FY2024 · AG · contact PI
Synergistic Interaction of amyloid-beta and alpha-synuclein in Lewy body Dementia$2,871,778
U54 · FY2023 · NS
Functional assessment of pathological α-syn and Aβ species in LBD$575,652
U54 · FY2023 · NS · contact PI
Mitochondrial Sirtuin 3 in Parkinson's disease$476,492
R01 · FY2023 · NS · contact PI
Synergistic Interaction of amyloid-beta and alpha-synuclein in Lewy body Dementia$2,879,931
U54 · FY2022 · NS
Functional assessment of pathological α-syn and Aβ species in LBD$575,587
U54 · FY2022 · NS · contact PI
Mitochondrial Sirtuin 3 in Parkinson's disease$476,492
R01 · FY2022 · NS · contact PI
Synergistic Interaction of amyloid-beta and alpha-synuclein in Lewy body Dementia$2,895,442
U54 · FY2021 · NS
Functional assessment of pathological α-syn and Aβ species in LBD$575,586
U54 · FY2021 · NS · contact PI
Mitochondrial Sirtuin 3 in Parkinson's disease$476,492
R01 · FY2021 · NS · contact PI
Mitochondrial Sirtuin 3 in Parkinson's disease$70,359
R01 · FY2021 · NS · contact PI
Synergistic Interaction of amyloid-beta and alpha-synuclein in Lewy body Dementia$2,903,188
U54 · FY2020 · NS
Functional assessment of pathological α-syn and Aβ species in LBD$575,587
U54 · FY2020 · NS · contact PI
Mitochondrial Sirtuin 3 in Parkinson's disease$476,492
R01 · FY2020 · NS · contact PI
Synergistic Interaction of amyloid-beta and alpha-synuclein in Lewy body Dementia$2,987,816
U54 · FY2019 · NS
Functional assessment of pathological α-syn and Aβ species in LBD$589,777
U54 · FY2019 · NS · contact PI
Mitochondrial Sirtuin 3 in Parkinson's disease$476,492
R01 · FY2019 · NS · contact PI
Mechanisms of alpha-synuclein accumulation in traumatic brain injury (R21 NS094908 Resubmission)$195,625
R21 · FY2017 · NS · contact PI
Mechanisms of alpha-synuclein accumulation in traumatic brain injury (R21 NS094908 Resubmission)$237,975
R21 · FY2016 · NS · contact PI
Extracellular alpha-synuclein in Parkinson's Disease$342,344
R01 · FY2015 · NS · contact PI
Extracellular alpha-synuclein in Parkinson's Disease$338,920
R01 · FY2014 · NS · contact PI
Extracellular alpha-synuclein in Parkinson's Disease$330,362
R01 · FY2013 · NS · contact PI
Role of oligomeric alpha-synuclein in synucleinopathies$323,755
R01 · FY2013 · NS · contact PI
Role of oligomeric alpha-synuclein in synucleinopathies$379,444
R01 · FY2012 · NS · contact PI
Extracellular alpha-synuclein in Parkinson's Disease$342,344
R01 · FY2012 · NS · contact PI
Role of oligomeric alpha-synuclein in synucleinopathies$379,444
R01 · FY2011 · NS · contact PI
Extracellular alpha-synuclein in Parkinson's Disease$225,000
R01 · FY2011 · NS · contact PI
Extracellular alpha-synuclein in Parkinson's Disease$145,016
R01 · FY2011 · NS · contact PI
Role of oligomeric alpha-synuclein in synucleinopathies$383,317
R01 · FY2010 · NS · contact PI
Role of oligomeric alpha-synuclein in synucleinopathies$386,642
R01 · FY2009 · NS · contact PI